- Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapyThe new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies suggest most of those who start taking GLP-1 drug…Endpoints · 3mo ago↗ source
- Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejectionSanofi’s tolebrutinib is on track to get an approval in Europe for a type of multiple sclerosis even after receiving a complete response letter from the FDA in December. On Friday, the European M…Endpoints · 3mo ago↗ source
- Pfizer’s strategy chief Andrew Baum steps down; Helus Pharma swaps out CEO after two months→ Ex-Citi analyst Andrew Baum has left his role as chief strategy and innovation officer at Pfizer, but he will be a senior strategic advisor to CEO Albert Bourla. BMO Capital Markets broke the new…